NCT00081250
Clinical Trial Information
Trial Number: NCT00081250 (ClinicalTrials.gov)
Disease Type:
- Miscellaneous Neoplasm - Other
Trial Title:
Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss
Study ID:
N02C4
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT00081250-D2 | Dataset NCT00081250-D2-Dataset.csv (demo) is one of 2 datasets associated with PubMed ID 28475678. This dataset contains information that will allow you to reproduce the baseline characteristics table, primary analysis, and adverse event analysis. |
| NCT00081250-D1 | Dataset NCT00081250-D1-Dataset.csv (qol) is one of 2 datasets associated with PubMed ID 28475678. This dataset contains information that will allow you to reproduce the primary analysis as well as other quality of life analyses. |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®